Clinical Trial Update: Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the efficacy and safety of Dysport in upper back myofascial pain syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome

Drugs mentioned

• Dysport (abobotulinumtoxinA)

Snippet

Sponsor: Ipsen | Conditions: Myofascial Pain Syndromes | Phase 2 | Status: COMPLETED